Enzymatic proteolysis has been implicated in diverse neuropathological conditions, including acute/subacute ischemic brain injuries and chronic neurodegeneration such as Alzheimer disease and Parkinson disease. Calcium-dependent proteases, calpains, have been intensively analyzed in relation to these pathological conditions, but in vivo experiments have been hampered by the lack of appropriate experimental systems for a selective regulation of the calpain activity in animals. Here we have generated transgenic (Tg) mice that overexpress human calpastatin, a specific and the only natural inhibitor of calpains. In order to clarify the distinct roles of these cell death-associated cysteine proteases, we dissected neurodegenerative changes in these mice together with Tg mice overexpressing a viral inhibitor of caspases after intrahippocampal injection of kainic acid (KA), an inducer of neuronal excitotoxicity. Immunohistochemical analyses using endo-specific antibodies against calpain-and caspase-cleaved cytoskeletal components revealed that preclusion of KA-induced calpain activation can rescue the hippocampal neurons from disruption of the neuritic cytoskeletons, whereas caspase suppression has no overt effect on the neuritic pathologies. In addition, progressive neuronal loss between the acute and subacute phases of KA-induced injury was largely halted only in human calpastatin Tg mice. The animal models and experimental paradigm employed here unequivocally demonstrate their usefulness for clarifying the distinct contribution of calpain and caspase systems to molecular mechanisms governing neurodegeneration in adult brains, and our results indicate the potentials of specific calpain inhibitors in ameliorating excitotoxic neuronal damages.Diverse proteolytic enzymes have been indicated to mediate molecular processes of neurodegeneration (1) because axonal, dendritic, and synaptic integrity is targeted by protease activities provoked by different types of insults (2-4). A family of nonlysosomal calcium-activated neutral cysteine proteases, referred to as calpain family (-and m-calpain isoforms in the present study), has been mechanistically implicated in the regulation of various cellular functions (5, 6). Because multiple lines of evidence indicate that neuronal cytoskeletal constituents, including microtubule-associated proteins (MAPs), 1 neurofilaments, spectrin, and actin, are preferred substrates for calpain (7-11), calpain is likely to play essential roles in the pathophysiological derangement of cytoskeletons. Acute and subacute brain insults such as traumatic injury and hypoxia/ ischemia involve prominent calpain activation evoked by calcium dysregulation in neurons. Moreover, several independent studies have highlighted the elevation of calpain activity in chronic neurodegenerative disorders including Alzheimer disease (12, 13) and Parkinson disease (14). However, it remains unclear whether the relationship between calpain activation and the disorganization of the neuronal cytoskeletons in these pathologies...